International symposium on pheochromocytoma: an event of dedicated healthcare professionals and researchers striving for better patient outcomes

Pheochromocytomas and paragangliomas (PPGLs) are defined as neuroendocrine tumors that produce catecholamines. Many recent advances in their management, localization, treatment, as well as surveillance have significantly improved outcomes for patients with PPGLs or carriers of pathogenic genetic variants linked to the development of these tumors. At present, those advances mainly include the molecular stratification of PPGLs into seven clusters, the 2017 WHO revised definition of these tumors, the presence of specific clinical features pointing toward PPGL, the use of plasma metanephrines and 3-methoxytyramine with specific reference limits to assess the likelihood of having a PPGL (e.g. patients at high and low risk) including age-specific reference limits, nuclear medicine guidelines outlining cluster- and metastatic disease-specific functional (here mainly positron emission tomography and metaiodobenzylguanidine scintigraphy) imaging in the precise diagnostic localization of PPGLs, the guidelines for using radio- vs chemotherapy for patients with metastatic disease, and the international consensus on initial screening and follow-up of asymptomatic germline SDHx pathogenic variant carriers. Furthermore, new collaborative efforts particularly based on multi-institutional and worldwide initiatives are now considered key forces in improving our understanding and knowledge about these tumors and future successful treatments or even preventative interventions.

Automated summary

Pheochromocytomas and paragangliomas (PPGLs) are neuroendocrine tumors that produce catecholamines. Recent advances in their management, localization, treatment, and surveillance have significantly improved outcomes for patients with PPGLs or carriers of pathogenic genetic variants linked to these tumors. Molecular stratification, revised definitions, specific clinical features, plasma biomarkers, imaging techniques, treatment guidelines, and international consensus play important roles in enhancing understanding and future interventions for PPGLs.